Axovant Shares Crater as CEO and Pres...

Axovant Shares Crater as CEO and President Both Resign

Shares of clinical-stage biotech firm Axovant Sciences plunged on Monday after it announced that its CEO, as well as its president and chief operating officer, had both resigned from the company. According to a press release, former CEO David Hung, who had been in the job for just 10 months, was leaving to pursue other opportunities, as was president and COO Marion McCourt.

Start the conversation, or

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Medivation Discussions

Title Updated Last By Comments
News Pricey prostate cancer drug's makers targeted b... (Mar '16) Mar '16 UTrashy 2
News Alzheimer's treatment sees major setback (Jan '12) Jan '12 ummhm 2
News The Dimebon Debacle (Apr '10) Apr '10 maggiekrane 1
News Pfizer And Medivation Agreement To Co-Develop A... (Oct '08) Oct '08 Alex 1